Sutro Biopharma, Inc. (STRO)
Sutro Biopharma Market Cap : 132.22M for Feb. 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 5.732M |
| Rhythm Pharmaceuticals, Inc. | 6.915B |
| Crinetics Pharmaceuticals, Inc. | 4.642B |
| ACADIA Pharmaceuticals, Inc. | 3.986B |
| Alnylam Pharmaceuticals, Inc. | 43.35B |
Market Cap Related Metrics
| PS Ratio | 3.978 |
| PEG Ratio | -0.0009 |
| Price | 15.52 |
| Earnings Yield | -114.4% |
| PEGY Ratio | -0.0009 |